By Nina Kienle Fresenius shares rose after the company posted better-than-expected adjusted earnings and organic revenue growth for the fourth quarter and.
In his latest research note, analyst James Vane-Tempest confirms his recommendation. The broker Jefferies is keeping its Neutral rating. The target price is unchanged and still at EUR 34.30.
In his latest research note, analyst James Vane-Tempest confirms his positive recommendation. The broker Jefferies is keeping its Buy rating. The target price is still set at EUR 120.
Initially Neutral on the company, Jefferies s analyst James Vane-Tempest maintained his recommendation. The target price is increased from EUR 264 to EUR 313.